Disclose an Invention

Connect with UIRF

Connect with any of our licensing team members to learn more or discuss your ideas.

View Available Technologies

Attend a Class

Learn about intellectual property, licensing, and commercialization at one of our virtual classes.

Unsure where to start?

Our staff are here to help guide UI innovators who want to commercialize new innovations.


Latest Innovations

Speleofilter: Pencil Beam Proton Therapy Configurator

Transdermal Patch for Sustained Drug Delivery

Particle Contamination Elimination in Semiconductor Manufacturing

Amplicon Based Genetic Screen

News feed

IIHR Innovation Day

Tuesday, September 26, 2023
Please join UIRF at the upcoming innovation day, October 10th, at the Stanley Hydraulics Lab. Agenda includes educational sessions on intellectual property and information for graduate students and post-docs. Lunch provided!

2024 Equalize pitch competition.

Established in 2020, Equalize is a comprehensive program designed to take national action around the disparity of women academic inventors forming university startups. Equalize participants receive education, a field-specific mentor, and access to networks that drive new entrepreneurial connections. If you would like to participate or have any questions, please feel free to reach out to a licensing associate.

hC Bioscience Moves to Boston's Seaport as Part of its Commitment to Employees and Innovation

Wednesday, July 12, 2023
hC Bioscience, co-founded by UI Faculty Dr. Chrisopher Ahern, has moved and consolidated its team to a new biotech-dedicated facility located in Boston's Seaport. The office, situated at 645 Summer Street, Suite 102, will serve as an important hub for hC Bioscience's continued growth and innovation in the field of tRNA.

Onel team uses LHC technology to develop a device used in radiation oncology

Wednesday, May 31, 2023
As part of his work in high-energy particle physics, Prof. Yasar Onel and his team have invented a scintillator that would be used in an ultra-fast radiation treatment for cancer.

UI engineering faculty members license inventions

Friday, April 7, 2023
Inventions of two University of Iowa College of Engineering faculty members have been licensed for commercial use. They are the latest technology transfer examples in which research emerging from UI laboratories is spun-out to a private company for broader public benefit.

Initial Results From First Patient Dosed With Perspective Therapeutics’ Lead Drug VMT-α-NET Presented at The Treatment of Neuroendocrine Disorders at the 2023 PET/RTRC Annual Workshop Scientific Session

Wednesday, March 29, 2023
Perspective, Therapeutics, Inc., a precision oncology company developing alpha-particle therapies and complementary diagnostic imaging agents based in-part on IP licensed from UIRF, and an innovator in seed brachytherapy powering expanding treatment options for multiple cancers, announced the presentation of extremely encouraging results regarding 212Pb-VMT-α-NET, its lead preclinical candidate for neuroendocrine tumors (NET), currently being used therapeutically in India on a compassionate use basis.

Cardio Diagnostics Holdings Inc Announces Expansion of IP Portfolio with Notice of Allowance of Patent Application

Thursday, March 9, 2023
Cardio Diagnostics Holdings, Inc., a pioneering precision cardiovascular medicine company founded by UI faculty Dr. Robert Philibert and UI graduate Dr. Meesha Dogan, today announced that China’s Patent Office has issued a Notice of Allowance to the University of Iowa Research Foundation (“UIRF”) for Chinese Patent Application No. 201780049286.4.


New Licenses and options granted to UI technologies



New patent applications



New invention disclosures